Cefdinir Powder, For Suspension
Product Images NDC 68788-8115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68788-8115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir For Oral Suspension Usp 125mg Per 5ml

Label for cefdinir for Oral Suspension, USP 125 mg/5 mL powder for suspension, generic for Omnicef. Includes preparation instructions, dosage information, and cautions. Manufactured by Ascend Laboratories, LLC. Features directions in both English and Spanish, with warnings and storage instructions. Labeler is Preferred Pharmaceuticals, Inc.*

FDA Label Image

Str-new (Str New)

Chemical structure of cefdinir, the active ingredient in the product. The diagram shows the molecular arrangement of atoms and bonds characteristic of cefdinir.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.